Kuros Biosciences earns patent for osteobiologic technology: 3 notes

Written by Shayna Korol | October 22, 2018 | Print  |

Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.

Here are three things to know:

1. The patent covers Kuros' technology for the production of osteoinductive calcium phosphates, which feature a surface topography designed to instruct stem cells and osteoprogenitor cells to differentiate into bone-forming cells.

2. The company is forming a patent portfolio and submitting patent applications to protects its proprietary MagnetOs product family.

3. MagnetOs is a bone graft substitute designed to fill bony voids or gaps to promote the bone formation at the implantation site.

More articles on biologics:
LifeNet Health unveils moldable osteobiologic solution for spine: 5 insights
ApoGraft-enriched stem cells show positive results in orthopedic application: 3 notes
Kuros Biosciences seeks spinal fusion product expansion: 4 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months